Literature DB >> 22464652

MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.

Sumitaka Yamanaka1, Alexandru V Olaru, Fangmei An, Delgermaa Luvsanjav, Zhe Jin, Rachana Agarwal, Ciprian Tomuleasa, Irinel Popescu, Sorin Alexandrescu, Simona Dima, Mihaela Chivu-Economescu, Elizabeth A Montgomery, Michael Torbenson, Stephen J Meltzer, Florin M Selaru.   

Abstract

BACKGROUND: A thorough understanding of gastric cancer at the molecular level is urgently needed. One prominent oncogenic microRNA, miR-21, was previously reported to be upregulated in gastric cancer.
METHODS: We performed an unbiased search for downstream messenger RNA targets of miR-21, based on miR-21 dysregulation, by using human tissue specimens and the MKN28 human gastric carcinoma cell line. Molecular techniques include microRNA microarrays, cDNA microarrays, qRT-PCR for miR and mRNA expression, transfection of MKN28 with miR-21 inhibitor or Serpini1 followed by Western blotting, cell cycle analysis by flow cytometry and luciferase reporter assay.
RESULTS: This search identified Serpini1 as a putative miR-21 target. Luciferase assays demonstrated direct interaction between miR-21 and Serpini1 3'UTR. miR-21 and Serpini1 expression levels were inversely correlated in a subgroup of gastric cancers, suggesting a regulatory mechanism that included both of these molecules. Furthermore, Serpini1 induced growth retardation of MKN28 and induced vigorous G1/S arrest suggesting its potential tumour-suppressive function in the stomach.
CONCLUSION: Taken together, these data suggest that in a subgroup of gastric cancers, miR-21 is upregulated, inducing downregulation of Serpini1, which in turn releases the G1-S transition checkpoint, with the end result being increased tumour growth.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464652      PMCID: PMC3360813          DOI: 10.1016/j.dld.2012.02.016

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  50 in total

1.  Global gene expression analysis of gastric cancer by oligonucleotide microarrays.

Authors:  Yoshitaka Hippo; Hirokazu Taniguchi; Shuichi Tsutsumi; Naoko Machida; Ja-Mun Chong; Masashi Fukayama; Tatsuhiko Kodama; Hiroyuki Aburatani
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

2.  Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.

Authors:  A S Fleisher; M Esteller; G Tamura; A Rashid; O C Stine; J Yin; T T Zou; J M Abraham; D Kong; S Nishizuka; S P James; K T Wilson; J G Herman; S J Meltzer
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

3.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

4.  Genetic alterations and expression of the protein phosphatase 1 genes in human cancers.

Authors:  S Takakura; T Kohno; R Manda; A Okamoto; T Tanaka; J Yokota
Journal:  Int J Oncol       Date:  2001-04       Impact factor: 5.650

5.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.

Authors:  M Toyota; N Ahuja; H Suzuki; F Itoh; M Ohe-Toyota; K Imai; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

6.  Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.

Authors:  T Tsuchiya; G Tamura; K Sato; Y Endoh; K Sakata; Z Jin; T Motoyama; O Usuba; W Kimura; S Nishizuka; K T Wilson; S P James; J Yin; A S Fleisher; T Zou; S G Silverberg; D Kong; S J Meltzer
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

7.  MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.

Authors:  Lei Shi; Jian Chen; Jian Yang; Tianhong Pan; Shuguang Zhang; Zhimin Wang
Journal:  Brain Res       Date:  2010-07-13       Impact factor: 3.252

8.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

9.  Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers.

Authors:  Yuriko Mori; Fumiaki Sato; Florin M Selaru; Andreea Olaru; Kellie Perry; Martha C Kimos; Gen Tamura; Nagahide Matsubara; Suna Wang; Yan Xu; Jing Yin; Tong-Tong Zou; Barbara Leggett; Joanne Young; Toshihiro Nukiwa; O Colin Stine; John M Abraham; David Shibata; Stephen J Meltzer
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

View more
  31 in total

1.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

Review 2.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 3.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

4.  A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.

Authors:  Alireza Ahadi
Journal:  Immunogenetics       Date:  2021-01-05       Impact factor: 2.846

5.  miRNA-Based Therapeutic Strategies.

Authors:  Masaharu Ishida; Florin M Selaru
Journal:  Curr Anesthesiol Rep       Date:  2012-12-24

6.  MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells.

Authors:  W Zhang; W Bai; W Zhang
Journal:  Clin Transl Oncol       Date:  2013-11-29       Impact factor: 3.405

7.  miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Hui Wang; Wei Chen; Nan Hu; Hesheng Ou
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 8.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682

9.  MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis.

Authors:  Xiu-Juan Liu; Quan Hong; Zhen Wang; Yan-yan Yu; Xin Zou; Li-hong Xu
Journal:  Mol Cell Biochem       Date:  2015-10-12       Impact factor: 3.396

Review 10.  BANCR: a cancer-related long non-coding RNA.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.